MARIANNE DUKE: Open Payments
NPI 1699207373 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$962 in 47 payments from 18 companies in 2025. Trend: 2023 $1,559 · 2024 $2,274 · 2025 $962
Food & beverage: $962
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $151 |
| Ascendis Pharma Endocrinology Inc | 2 | $131 |
| Novo Nordisk Inc | 7 | $121 |
| CeQur Corporation | 1 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $69 |
| Radius Health, Inc. | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Corcept Therapeutics | 2 | $41 |
| Tandem Diabetes Care, Inc. | 4 | $39 |
| Amgen Inc. | 2 | $38 |
Products named: Yorvipath, JARDIANCE, CeQur Simplicity, Ozempic, MOUNJARO, Tymlos, LEQVIO, Korlym.
Industry payments across IN — which companies pay providers there.
